These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-3672603
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
12300 Grant Street, Thornton, CO
|
|
80241
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
|
o
|
|
Accelerated filer
|
|
o
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
Emerging growth company
|
|
o
|
|
|
|
|
|
|
||
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
ASSETS
|
|
(Unaudited)
|
|
|
||||
|
Current Assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
88,111
|
|
|
$
|
89,618
|
|
|
Trade receivables, net of allowance for doubtful accounts of $35,251 and $48,201, respectively
|
|
13,984
|
|
|
6,658
|
|
||
|
Inventories, net
|
|
1,074,319
|
|
|
1,037,854
|
|
||
|
Prepaid expenses and other current assets
|
|
520,944
|
|
|
494,425
|
|
||
|
Total current assets
|
|
1,697,358
|
|
|
1,628,555
|
|
||
|
Property, Plant and Equipment
|
|
36,645,862
|
|
|
36,645,862
|
|
||
|
Less accumulated depreciation and amortization
|
|
(32,072,422
|
)
|
|
(32,013,686
|
)
|
||
|
|
|
4,573,440
|
|
|
4,632,176
|
|
||
|
Other Assets:
|
|
|
|
|
||||
|
Patents, net of accumulated amortization of $440,805 and $430,071, respectively
|
|
1,376,785
|
|
|
1,470,796
|
|
||
|
Other non-current assets
|
|
42,875
|
|
|
49,813
|
|
||
|
|
|
1,419,660
|
|
|
1,520,609
|
|
||
|
Total Assets
|
|
$
|
7,690,458
|
|
|
$
|
7,781,340
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
|
|
|
||||
|
Current Liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
1,901,411
|
|
|
$
|
1,600,455
|
|
|
Related party payables
|
|
208,754
|
|
|
202,827
|
|
||
|
Accrued expenses
|
|
2,094,885
|
|
|
1,623,748
|
|
||
|
Notes payable
|
|
1,567,731
|
|
|
1,570,231
|
|
||
|
Current portion of long-term debt
|
|
349,092
|
|
|
343,395
|
|
||
|
Current portion of secured promissory note, net of discount of $2,595,172 and $1,934,304, respectively
|
|
822,978
|
|
|
253,590
|
|
||
|
Promissory Notes, net of discount of $15,000 and $20,626, respectively
|
|
984,437
|
|
|
948,811
|
|
||
|
October 2016 convertible notes
|
|
330,000
|
|
|
330,000
|
|
||
|
St. George convertible note, net of discount and cash payment premium of $528,975 and $673,241, respectively
|
|
1,101,858
|
|
|
1,032,592
|
|
||
|
BayBridge convertible note, net of discount of $423,750 and $565,000, respectively
|
|
36,250
|
|
|
—
|
|
||
|
Embedded derivative liabilities
|
|
8,109,081
|
|
|
6,406,833
|
|
||
|
Total current liabilities
|
|
17,506,477
|
|
|
14,312,482
|
|
||
|
|
|
|
|
|
||||
|
Long-term debt, net of current portion
|
|
5,028,985
|
|
|
5,118,424
|
|
||
|
Long-term secured promissory note, net of current portion, and net of discount of $1,454,595 and $1,684,267, respectively
|
|
30,603
|
|
|
685,066
|
|
||
|
Accrued Warranty Liability
|
|
51,358
|
|
|
57,703
|
|
||
|
|
|
|
|
|
||||
|
Commitments and Contingencies
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
Mezzanine Equity:
|
|
|
|
|
||||
|
Series K preferred stock: 20,000 shares authorized; 2,810 issued and outstanding, respectively
|
|
2,810,000
|
|
|
2,810,000
|
|
||
|
|
|
|
|
|
||||
|
Stockholders’ Deficit:
|
|
|
|
|
||||
|
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 60,756 shares issued and outstanding, respectively ($776,845 and $761,864 Liquidation Preference)
|
|
6
|
|
|
6
|
|
||
|
Common stock, $0.0001 par value, 20,000,000,000 shares authorized; 12,738,048,718 and 9,606,597,777 shares issued and outstanding, respectively
|
|
1,273,809
|
|
|
960,660
|
|
||
|
Additional paid in capital
|
|
387,917,742
|
|
|
386,332,475
|
|
||
|
Accumulated deficit
|
|
(406,928,522
|
)
|
|
(402,495,476
|
)
|
||
|
Total stockholders’ deficit
|
|
(17,736,965
|
)
|
|
(15,202,335
|
)
|
||
|
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit
|
|
$
|
7,690,458
|
|
|
$
|
7,781,340
|
|
|
|
|
For the Three Months Ended
|
|
||||||
|
|
|
March 31,
|
|
||||||
|
|
|
2018
|
|
2017
|
|
||||
|
|
|
|
|
|
|
||||
|
Revenues
|
|
$
|
377,511
|
|
|
$
|
280,603
|
|
|
|
|
|
|
|
|
|
||||
|
Costs and Expenses:
|
|
|
|
|
|
||||
|
Cost of revenues (exclusive of depreciation shown below)
|
|
273,028
|
|
|
1,492,841
|
|
|
||
|
Research, development and manufacturing operations (exclusive of depreciation shown below)
|
|
1,173,035
|
|
|
1,276,865
|
|
|
||
|
Inventory impairment costs
|
|
—
|
|
|
363,758
|
|
|
||
|
Selling, general and administrative (exclusive of depreciation shown below)
|
|
934,591
|
|
|
1,764,230
|
|
|
||
|
Depreciation and amortization
|
|
101,712
|
|
|
371,653
|
|
|
||
|
Total Costs and Expenses
|
|
2,482,366
|
|
|
5,269,347
|
|
|
||
|
Loss from Operations
|
|
(2,104,855
|
)
|
|
(4,988,744
|
)
|
|
||
|
|
|
|
|
|
|
||||
|
Other Income/(Expense)
|
|
|
|
|
|
||||
|
Other Income/(Expense), net
|
|
—
|
|
|
728,485
|
|
|
||
|
Interest expense
|
|
(1,343,730
|
)
|
|
(1,991,352
|
)
|
|
||
|
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net
|
|
(984,461
|
)
|
|
673,078
|
|
|
||
|
Total Other Income/(Expense)
|
|
(2,328,191
|
)
|
|
(589,789
|
)
|
|
||
|
Net Loss
|
|
$
|
(4,433,046
|
)
|
|
$
|
(5,578,533
|
)
|
|
|
|
|
|
|
|
|
||||
|
Net Loss Per Share (Basic and diluted)
|
|
$
|
(0.0004
|
)
|
|
$
|
(0.0033
|
)
|
|
|
Weighted Average Common Shares Outstanding (Basic and diluted)
|
|
10,996,378,097
|
|
|
1,665,310,868
|
|
|
||
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
|||||||||
|
|
|||||||||
|
(Unaudited)
|
|||||||||
|
|
|||||||||
|
|
|
three months ended
|
|
||||||
|
|
|
March 31,
|
|
||||||
|
|
|
2018
|
|
2017
|
|
||||
|
Operating Activities:
|
|
|
|
|
|
||||
|
Net loss
|
|
$
|
(4,433,046
|
)
|
|
$
|
(5,578,533
|
)
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
||||||
|
Depreciation and amortization
|
|
101,712
|
|
|
371,653
|
|
|
||
|
Share based compensation
|
|
14,324
|
|
|
79,737
|
|
|
||
|
Realized gain on sale of assets
|
|
—
|
|
|
(1,205,663
|
)
|
|
||
|
Amortization of financing costs to interest expense
|
|
3,333
|
|
|
35,164
|
|
|
||
|
Non-cash interest expense
|
|
222,648
|
|
|
575,015
|
|
|
||
|
Amortization of debt discount
|
|
1,011,109
|
|
|
1,474,135
|
|
|
||
|
Bad debt expense
|
|
—
|
|
|
4,082
|
|
|
||
|
Accrued litigation settlement
|
|
—
|
|
|
(143,266
|
)
|
|
||
|
Write-down of inventory
|
|
—
|
|
|
363,758
|
|
|
||
|
Write down of patents
|
|
59,153
|
|
|
—
|
|
|
||
|
Warranty reserve
|
|
(6,345
|
)
|
|
(7,489
|
)
|
|
||
|
Change in fair value of derivatives and (gain)/loss on extinguishment of liabilities, net
|
|
984,461
|
|
|
(673,078
|
)
|
|
||
|
Inducement conversion costs
|
|
—
|
|
|
407,974
|
|
|
||
|
Changes in operating assets and liabilities:
|
|
||||||||
|
Accounts receivable
|
|
(1,326
|
)
|
|
533,822
|
|
|
||
|
Inventories
|
|
(36,465
|
)
|
|
899,915
|
|
|
||
|
Prepaid expenses and other current assets
|
|
(29,852
|
)
|
|
394,550
|
|
|
||
|
Accounts payable
|
|
244,975
|
|
|
(249,691
|
)
|
|
||
|
Related party payable
|
|
5,927
|
|
|
—
|
|
|
||
|
Accrued expenses
|
|
364,648
|
|
|
56,721
|
|
|
||
|
Net cash used in operating activities
|
|
(1,494,744
|
)
|
|
(2,661,194
|
)
|
|
||
|
Investing Activities:
|
|
|
|
|
|
||||
|
Proceeds from the sale of assets
|
|
—
|
|
|
150,000
|
|
|
||
|
Patent activity costs
|
|
(6,502
|
)
|
|
(19,275
|
)
|
|
||
|
Net cash provided by/(used in) investing activities
|
|
(6,502
|
)
|
|
130,725
|
|
|
||
|
Financing Activities:
|
|
|
|
|
|
||||
|
Proceeds from issuance of debt
|
|
1,530,000
|
|
|
2,340,000
|
|
|
||
|
Proceeds from issuance of stock
|
|
—
|
|
|
150,000
|
|
|
||
|
Payment of debt financing costs
|
|
—
|
|
|
(42,500
|
)
|
|
||
|
Repayment of debt
|
|
(30,261
|
)
|
|
—
|
|
|
||
|
Net cash provided by financing activities
|
|
1,499,739
|
|
|
2,447,500
|
|
|
||
|
Net change in cash and cash equivalents
|
|
(1,507
|
)
|
|
(82,969
|
)
|
|
||
|
Cash and cash equivalents at beginning of period
|
|
89,618
|
|
|
130,946
|
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
88,111
|
|
|
$
|
47,977
|
|
|
|
Supplemental Cash Flow Information:
|
|
|
|
|
|
||||
|
Cash paid for interest
|
|
$
|
106,617
|
|
|
$
|
20,415
|
|
|
|
Cash paid for income taxes
|
|
—
|
|
|
—
|
|
|
||
|
Non-Cash Transactions:
|
|
|
|
|
|
||||
|
Non-cash conversions of convertible notes and preferred stock
|
|
$
|
1,430,000
|
|
|
$
|
1,699,731
|
|
|
|
Interest converted to principal
|
|
$
|
96,120
|
|
|
$
|
—
|
|
|
|
Initial derivatives
|
|
$
|
1,151,162
|
|
|
$
|
—
|
|
|
|
Make-whole dividend
|
|
$
|
—
|
|
|
$
|
257,152
|
|
|
|
Accounts payable converted to notes payable
|
|
$
|
—
|
|
|
$
|
1,172,026
|
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2018
|
|
2017
|
||||
|
Building
|
|
$
|
5,828,960
|
|
|
$
|
5,828,960
|
|
|
Furniture, fixtures, computer hardware and computer software
|
|
489,421
|
|
|
489,421
|
|
||
|
Manufacturing machinery and equipment
|
|
30,327,481
|
|
|
30,327,481
|
|
||
|
Property, plant and equipment
|
|
36,645,862
|
|
|
36,645,862
|
|
||
|
Less: Accumulated depreciation and amortization
|
|
(32,072,422
|
)
|
|
(32,013,686
|
)
|
||
|
Net property, plant and equipment
|
|
$
|
4,573,440
|
|
|
$
|
4,632,176
|
|
|
|
|
As of March 31,
|
|
As of December 31,
|
||||
|
|
|
2018
|
|
2017
|
||||
|
Raw materials
|
|
$
|
695,474
|
|
|
$
|
688,904
|
|
|
Work in process
|
|
5,106
|
|
|
11,878
|
|
||
|
Finished goods
|
|
373,739
|
|
|
337,072
|
|
||
|
Total
|
|
$
|
1,074,319
|
|
|
$
|
1,037,854
|
|
|
|
|
||
|
2018
|
$
|
259,654
|
|
|
2019
|
366,757
|
|
|
|
2020
|
391,709
|
|
|
|
2021
|
418,358
|
|
|
|
2022
|
446,821
|
|
|
|
Thereafter
|
3,494,778
|
|
|
|
|
$
|
5,378,077
|
|
|
Closing Date
|
Closing Amount
|
Maturity Date
|
||
|
11/30/2017
|
$
|
250,000
|
|
11/30/2018
|
|
12/28/2017
|
$
|
250,000
|
|
12/28/2018
|
|
1/11/2018
|
$
|
250,000
|
|
1/11/2019
|
|
1/25/2018
|
$
|
250,000
|
|
1/25/2019
|
|
2/8/2018
|
$
|
250,000
|
|
2/8/2019
|
|
2/21/2018
|
$
|
250,000
|
|
2/21/2019
|
|
3/7/2018
|
$
|
250,000
|
|
3/7/2019
|
|
3/21/2018
|
$
|
250,000
|
|
3/21/2019
|
|
1)
|
The first valuation was done on the November 30, 2017 Note with term of
three
years. The derivative value of this note was
$3,742,002
as of
December 31, 2017
.
|
|
1)
|
The second valuation was done on the group of Notes dated November 30, 2017, that had a term of
one
year. The derivative value of this group of notes was
$888,168
as of
December 31, 2017
.
|
|
2)
|
The third valuation was done on the Note dated December 28, 2017, which had a term of
one
year. The derivative value of this note was
$267,008
on
December 31, 2017
.
|
|
3)
|
For the Notes dated in the first quarter of
2018
, we did a fourth valuation. Although the notes were entered into at various dates, we used a weighted average issuance date of
February 15, 2018
for a combined valuation purpose. Management's analysis, using the following assumptions: annual volatility of
54%
present value discount rate of
12%
and a dividend yield of
0%
, resulted in a fair value of the embedded derivative associated with these Notes of
$1,151,162
as of
February 15, 2018
. The value of the embedded derivative associated with these Notes was recorded as a debt discount.
|
|
1)
|
For the November 30, 2017 3yr Note: Management conducted a fair value assessment with the following assumptions: annual volatility of
64%
present value discount rate of
12%
and a dividend yield of
0%
as of
March 31, 2018
. As a result of the fair value assessment, the Company recorded a gain of
$612,155
as "Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net" in the Consolidated Statements of Operations to properly reflect the fair value of the embedded derivative of
$3,129,847
as of
March 31, 2018
.
|
|
2)
|
For the November 30, 2017 1yr Notes: Management conducted a fair value assessment with the following assumptions: annual volatility of
52%
present value discount rate of
12%
and a dividend yield of
0%
as of
March 31, 2018
. As a result of the fair value assessment, the Company recorded a gain of
$174,989
as "Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net" in the Consolidated Statements of Operations to properly reflect the fair value of the embedded derivative of
$713,179
as of
March 31, 2018
.
|
|
3)
|
For the December 28, 2017 1yr Note: Management conducted a fair value assessment with the following assumptions: annual volatility of
52%
present value discount rate of
12%
and a dividend yield of
0%
as of
March 31, 2018
. As a result of the fair value assessment, the Company recorded a gain of
$78,871
as "Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net" in the Consolidated Statements of Operations to properly reflect the fair value of the embedded derivative of
$188,137
as of
March 31, 2018
.
|
|
4)
|
For the first quarter
2018
1yr Notes: Management conducted a fair value assessment with the following assumptions: annual volatility of
52%
present value discount rate of
12%
and a dividend yield of
0%
as of
March 31, 2018
. As a result of the fair value assessment, the Company recorded a loss of
$878,973
as "Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net" in the Consolidated Statements of Operations to properly reflect the fair value of the embedded derivative of
$2,030,135
as of
March 31, 2018
.
|
|
Closing Period
|
Preferred Series K Shares Purchased
|
Closing Amount
|
|||
|
Q1 2017
|
150
|
|
$
|
150,000
|
|
|
Q2 2017
|
4,100
|
|
4,100,000
|
|
|
|
Q3 2017
|
4,760
|
|
$
|
4,760,000
|
|
|
|
9,010
|
|
$
|
9,010,000
|
|
|
Conversion Period
|
Preferred Series K Shares Converted
|
Value of Series K Preferred Shares
|
Common Shares Issued
|
||||
|
Q2 2017
|
3,200
|
|
$
|
3,200,000
|
|
800,000,000
|
|
|
Q3 2017
|
3,000
|
|
$
|
3,000,000
|
|
750,000,000
|
|
|
|
6,200
|
|
$
|
6,200,000
|
|
1,550,000,000
|
|
|
Preferred Stock Series Designation
|
Shares Outstanding
|
|
|
Series A
|
60,756
|
|
|
Series K
|
2,810
|
|
|
|
Warrant
Shares |
Warrant
Weighted Average Exercise Price |
|||
|
Outstanding at December 31, 2016
|
—
|
|
$
|
—
|
|
|
Granted
|
700,000,000
|
|
$
|
0.003
|
|
|
Exercised
|
—
|
|
$
|
—
|
|
|
Canceled
|
—
|
|
$
|
—
|
|
|
Outstanding at December 31, 2017
|
700,000,000
|
|
$
|
0.003
|
|
|
Granted
|
—
|
|
$
|
—
|
|
|
Exercised
|
—
|
|
$
|
—
|
|
|
Canceled
|
—
|
|
$
|
—
|
|
|
Outstanding at March 31, 2018
|
700,000,000
|
|
$
|
0.003
|
|
|
Exercisable at March 31, 2018
|
700,000,000
|
|
$
|
0.003
|
|
|
|
|
For the three months ended March 31,
|
|
||||||
|
|
|
2018
|
|
2017
|
|
||||
|
Share-based compensation cost included in:
|
|
|
|
|
|
||||
|
Research and development
|
|
$
|
454
|
|
|
$
|
16,610
|
|
|
|
Selling, general and administrative
|
|
13,870
|
|
|
63,127
|
|
|
||
|
Total share-based compensation cost
|
|
$
|
14,324
|
|
|
$
|
79,737
|
|
|
|
|
|
For the three months ended March 31,
|
|
||||||
|
|
|
2018
|
|
2017
|
|
||||
|
Type of Award:
|
|
|
|
|
|
||||
|
Stock Options
|
|
$
|
14,324
|
|
|
$
|
53,408
|
|
|
|
Restricted Stock Units and Awards
|
|
—
|
|
|
26,329
|
|
|
||
|
Total share-based compensation cost
|
|
$
|
14,324
|
|
|
$
|
79,737
|
|
|
|
•
|
Our ability to generate customer acceptance of and demand for our products;
|
|
•
|
Successful ramping up of commercial production on the equipment installed;
|
|
•
|
Our products are successfully and timely certified for use in our target markets;
|
|
•
|
Successful operating of production tools to achieve the efficiencies, throughput and yield necessary to reach our cost targets;
|
|
•
|
The products we design are saleable at a price sufficient to generate profits;
|
|
•
|
Our ability to raise sufficient capital to enable us to reach a level of sales sufficient to achieve profitability on terms favorable to us;
|
|
•
|
Effective management of the planned ramp up of our domestic and international operations;
|
|
•
|
Our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, retailers and e-commerce companies, who deal directly with end users in our target markets;
|
|
•
|
Our ability to maintain the listing of our common stock on the OTC Market;
|
|
•
|
Our ability to implement remediation measures to address material weaknesses in internal control;
|
|
•
|
Our ability to achieve projected operational performance and cost metrics;
|
|
•
|
Our ability to enter into commercially viable licensing, joint venture, or other commercial arrangements; and
|
|
•
|
Availability of raw materials.
|
|
1.
|
Personnel and facility related expenses decreased approximately
$83,000
, as compared to the
first
quarter of
2017
. The decrease in personnel and facility related costs was primarily due to a reduction in headcount.
|
|
2.
|
Consulting and contract services decreased approximately
$11,000
, as compared to the
first
quarter of
2017
. The decrease in expense as compared to the
first
quarter of
2017
was primarily attributed to the reduced number of contractors during the quarter ended
March 31, 2018
.
|
|
3.
|
Materials and equipment related expenses, decreased approximately
$9,000
, as compared to the
first
quarter of
2017
. The decrease was due to a decrease in production of research and development products.
|
|
1.
|
Personnel and facility related costs decreased approximately
$361,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. The overall decrease in personnel related costs was primarily due a lower headcount for the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
.
|
|
2.
|
Marketing and related expenses decreased approximately
$83,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. The decrease in Marketing and related expenses is due to reduced marketing, advertising, and promotional activities during the three months ended
March 31, 2018
, compared to the
first
quarter of
2017
, which is the direct result of changing our main focus from the retail consumer electronics market to higher-value PV markets.
|
|
3.
|
Consulting and contract services decreased approximately
$354,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. The decrease was a result of decreased use of consultants and contractors.
|
|
4.
|
Legal expenses increased approximately
$92,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. The primary reasons for the increase is due increased and general legal expenses related to financing efforts as compared to the quarter ended
March 31, 2017
, offset by decreases in legal expenses related to our patent activity as compared to the
first
quarter of
2017
.
|
|
5.
|
Bad debt and settlement expenses decreased approximately
$45,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. During the first quarter of 2017 we recorded payments and settlements against existing reserves which were offset by additional reserves for customers whose accounts were greater than 120 days overdue.
|
|
6.
|
Public company expenses decreased approximately
$78,000
during the three months ended
March 31, 2018
, as compared to the three months ended
March 31, 2017
. The decrease is mostly due to reduced SEC filings and a decrease in public relations expense.
|
|
1.
|
Interest expense decreased approximately
$648,000
, as compared the
first
quarter of
2017
. The decrease is primarily due to an decrease of non-cash interest expense related to convertible debt, promissory notes, and Preferred Stock.
|
|
2.
|
Gains and losses on change in fair value of derivatives and on extinguishment of liabilities, net was a loss of approximately
$984,000
during the
first
quarter of
2018
, as compared to an approximate gain of
$673,000
for the
first
quarter of
2017
. The increased expense of approximately
$1,658,000
in this non-cash item is attributable to a loss of approximately
$551,000
on the change in fair value of our embedded derivative instruments during the three months ended
March 31, 2018
, compared to an approximate gain
$3,256,000
in
2017
, offset by a reduction in the loss from extinguishment of liabilities of approximately
$2,149,000
, related to conversions and redemptions of certain convertible notes and preferred stock, for the three months ended
March 31, 2018
, as compared to the the three months ended
March 31, 2017
|
|
|
|
Decrease (Increase)
to Net Loss
For the Three
Months Ended
March 31, 2018 Compared to the Three Months Ended
March 31, 2017
|
||
|
Revenues
|
|
97,000
|
|
|
|
Cost of Revenue
|
|
1,220,000
|
|
|
|
Research, development and manufacturing operations
|
|
|
||
|
Materials and Equipment Related Expenses
|
|
9,000
|
|
|
|
Personnel and Facility Related Expenses
|
|
83,000
|
|
|
|
Consulting and Contract Services
|
|
11,000
|
|
|
|
Inventory Impairment Costs
|
|
364,000
|
|
|
|
Selling, general and administrative expenses
|
|
|
||
|
Personnel, administrative, and facility Related Expenses
|
|
361,000
|
|
|
|
Marketing Related Expenses
|
|
83,000
|
|
|
|
Legal Expenses
|
|
(92,000
|
)
|
|
|
Public Company Costs
|
|
78,000
|
|
|
|
Consulting and Contract Services
|
|
354,000
|
|
|
|
Bad debt and Settlement expense
|
|
45,000
|
|
|
|
Depreciation and Amortization Expense
|
|
270,000
|
|
|
|
Other Income / (Expense)
|
|
|
||
|
Other income
|
|
728,000
|
|
|
|
Interest Expense
|
|
(648,000
|
)
|
|
|
Non-Cash Change in Fair Value of Derivatives and Gain/Loss on Extinguishment of Liabilities, net
|
|
1,658,000
|
|
|
|
Decrease (Increase) to Net Loss
|
|
$
|
1,145,000
|
|
|
|
|
|
|
Payments by Year
|
|||||||||||||
|
Contractual Obligation
|
|
Total
|
|
Less than 1 year
|
1-3 Years
|
3-5 Years
|
More than 5 Years
|
||||||||||
|
Long Term Debt
|
|
$
|
6,834,440
|
|
|
$
|
693,611
|
|
$
|
2,080,832
|
|
$
|
2,080,832
|
|
$
|
1,979,165
|
|
|
Purchase Obligations
|
|
$
|
423,297
|
|
|
423,297
|
|
|
|
|
|||||||
|
|
|
$
|
7,257,737
|
|
|
$
|
1,116,908
|
|
$
|
2,080,832
|
|
$
|
2,080,832
|
|
$
|
1,979,165
|
|
|
Exhibit No.
|
|
Description
|
|
10.1
|
|
|
|
10.2
|
|
|
|
31.1*
|
|
|
|
31.2*
|
|
|
|
32.1*
|
|
|
|
32.2*
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
*
|
|
Filed herewith
|
|
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
By:
|
/
S
/ VICTOR LEE
|
|
|
|
Lee Kong Hian (aka Victor Lee)
President and Chief Executive Officer
(Principal Executive Officer, Principal Financial Officer, Chief Accounting Officer, and Authorized Signatory)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|